Literature DB >> 28541529

Statistical algorithms improve accuracy of gene fusion detection.

Gillian Hsieh1, Rob Bierman1, Linda Szabo2, Alex Gia Lee3, Donald E Freeman1, Nathaniel Watson1, E Alejandro Sweet-Cordero3, Julia Salzman1,4.   

Abstract

Gene fusions are known to play critical roles in tumor pathogenesis. Yet, sensitive and specific algorithms to detect gene fusions in cancer do not currently exist. In this paper, we present a new statistical algorithm, MACHETE (Mismatched Alignment CHimEra Tracking Engine), which achieves highly sensitive and specific detection of gene fusions from RNA-Seq data, including the highest Positive Predictive Value (PPV) compared to the current state-of-the-art, as assessed in simulated data. We show that the best performing published algorithms either find large numbers of fusions in negative control data or suffer from low sensitivity detecting known driving fusions in gold standard settings, such as EWSR1-FLI1. As proof of principle that MACHETE discovers novel gene fusions with high accuracy in vivo, we mined public data to discover and subsequently PCR validate novel gene fusions missed by other algorithms in the ovarian cancer cell line OVCAR3. These results highlight the gains in accuracy achieved by introducing statistical models into fusion detection, and pave the way for unbiased discovery of potentially driving and druggable gene fusions in primary tumors.
© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28541529      PMCID: PMC5737606          DOI: 10.1093/nar/gkx453

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  40 in total

1.  A new translocation t(9;11)(q34;p15) fuses NUP98 to a novel homeobox partner gene, PRRX2, in a therapy-related acute myeloid leukemia.

Authors:  C Gervais; L Mauvieux; N Perrusson; C Hélias; S Struski; V Leymarie; B Lioure; M Lessard
Journal:  Leukemia       Date:  2005-01       Impact factor: 11.528

2.  EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.

Authors:  Nicolò Riggi; Birgit Knoechel; Shawn M Gillespie; Bradley E Bernstein; Miguel N Rivera; Esther Rheinbay; Gaylor Boulay; Mario L Suvà; Nikki E Rossetti; Wannaporn E Boonseng; Ozgur Oksuz; Edward B Cook; Aurélie Formey; Anoop Patel; Melissa Gymrek; Vishal Thapar; Vikram Deshpande; David T Ting; Francis J Hornicek; G Petur Nielsen; Ivan Stamenkovic; Martin J Aryee
Journal:  Cancer Cell       Date:  2014-10-30       Impact factor: 31.743

3.  CH5424802, a selective ALK inhibitor capable of blocking the resistant gatekeeper mutant.

Authors:  Hiroshi Sakamoto; Toshiyuki Tsukaguchi; Sayuri Hiroshima; Tatsushi Kodama; Takamitsu Kobayashi; Takaaki A Fukami; Nobuhiro Oikawa; Takuo Tsukuda; Nobuya Ishii; Yuko Aoki
Journal:  Cancer Cell       Date:  2011-05-17       Impact factor: 31.743

4.  Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

Authors:  Ellen Weisberg; Christina Boulton; Louise M Kelly; Paul Manley; Doriano Fabbro; Thomas Meyer; D Gary Gilliland; James D Griffin
Journal:  Cancer Cell       Date:  2002-06       Impact factor: 31.743

5.  The role of Nup98 in transcription regulation in healthy and diseased cells.

Authors:  Tobias M Franks; Martin W Hetzer
Journal:  Trends Cell Biol       Date:  2012-12-13       Impact factor: 20.808

6.  State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues?

Authors:  Matteo Carrara; Marco Beccuti; Federica Cavallo; Susanna Donatelli; Fulvio Lazzarato; Francesca Cordero; Raffaele A Calogero
Journal:  BMC Bioinformatics       Date:  2013-04-22       Impact factor: 3.169

7.  The landscape and therapeutic relevance of cancer-associated transcript fusions.

Authors:  K Yoshihara; Q Wang; W Torres-Garcia; S Zheng; R Vegesna; H Kim; R G W Verhaak
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

8.  Transcriptome sequencing to detect gene fusions in cancer.

Authors:  Christopher A Maher; Chandan Kumar-Sinha; Xuhong Cao; Shanker Kalyana-Sundaram; Bo Han; Xiaojun Jing; Lee Sam; Terrence Barrette; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

9.  A large genome center's improvements to the Illumina sequencing system.

Authors:  Michael A Quail; Iwanka Kozarewa; Frances Smith; Aylwyn Scally; Philip J Stephens; Richard Durbin; Harold Swerdlow; Daniel J Turner
Journal:  Nat Methods       Date:  2008-12       Impact factor: 28.547

10.  Signatures of selection in fusion transcripts resulting from chromosomal translocations in human cancer.

Authors:  Iñigo Ortiz de Mendíbil; José L Vizmanos; Francisco J Novo
Journal:  PLoS One       Date:  2009-03-12       Impact factor: 3.240

View more
  3 in total

1.  Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers.

Authors:  Roozbeh Dehghannasiri; Donald E Freeman; Milos Jordanski; Gillian L Hsieh; Ana Damljanovic; Erik Lehnert; Julia Salzman
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-15       Impact factor: 11.205

2.  A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine.

Authors:  Izumi V Hinkson; Tanja M Davidsen; Juli D Klemm; Anthony R Kerlavage; Warren A Kibbe; Ishwar Chandramouliswaran
Journal:  Front Cell Dev Biol       Date:  2017-09-21

3.  Specific splice junction detection in single cells with SICILIAN.

Authors:  Roozbeh Dehghannasiri; Julia Eve Olivieri; Ana Damljanovic; Julia Salzman
Journal:  Genome Biol       Date:  2021-08-05       Impact factor: 13.583

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.